XBIO - Xenetic Biosciences, Inc.

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Currency in USD

Valuation Measures

Market Cap (intraday) 54.22M
Enterprise Value 32.25M
Trailing P/E N/A
Forward P/E 1N/A
PEG Ratio (5 yr expected) 1N/A
Price/Sales (ttm)N/A
Price/Book (mrq)0.37
Enterprise Value/Revenue 3N/A
Enterprise Value/EBITDA 6-0.33

Trading Information

Stock Price History

Beta (3Y Monthly) 2.56
52-Week Change 3-87.98%
S&P500 52-Week Change 36.70%
52 Week High 355.2000
52 Week Low 34.5700
50-Day Moving Average 38.5586
200-Day Moving Average 317.8345

Share Statistics

Avg Vol (3 month) 376.4k
Avg Vol (10 day) 3221.2k
Shares Outstanding 59.4M
Float 283.74k
% Held by Insiders 158.20%
% Held by Institutions 110.98%
Shares Short (Jun 28, 2019) 483.9k
Short Ratio (Jun 28, 2019) 41.13
Short % of Float (Jun 28, 2019) 419.84%
Short % of Shares Outstanding (Jun 28, 2019) 49.64%
Shares Short (prior month May 31, 2019) 44.52k

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor (new per old) 212/1
Last Split Date 3Jun 25, 2019

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2018
Most Recent Quarter (mrq)Mar 31, 2019

Profitability

Profit Margin 0.00%
Operating Margin (ttm)0.00%

Management Effectiveness

Return on Assets (ttm)-24.91%
Return on Equity (ttm)-55.77%

Income Statement

Revenue (ttm)N/A
Revenue Per Share (ttm)N/A
Quarterly Revenue Growth (yoy)N/A
Gross Profit (ttm)N/A
EBITDA -6.76M
Net Income Avi to Common (ttm)-10.68M
Diluted EPS (ttm)-13.7690
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)2.02M
Total Cash Per Share (mrq)2.32
Total Debt (mrq)39.35k
Total Debt/Equity (mrq)0.34
Current Ratio (mrq)1.60
Book Value Per Share (mrq)13.23

Cash Flow Statement

Operating Cash Flow (ttm)-6.05M
Levered Free Cash Flow (ttm)-3.5M